News & Updates

Semaglutide benefits extend to HFpEF patients with T2D

04 May 2024 by

The weight loss and heart failure (HF) benefits of semaglutide extend to patients with obesity-related HF with preserved ejection fraction (HFpEF) and type 2 diabetes (T2D) in the STEP-HFpEF DM trial, fuelling speculation that semaglutide may have cardiovascular effects beyond weight loss.

Semaglutide benefits extend to HFpEF patients with T2D

04 May 2024

Prognosis role of blood urea nitrogen to serum albumin ratio established in IPAH

03 May 2024

A higher ratio of blood urea nitrogen to serum albumin is indicative of worse outcomes and disease severity in patients with idiopathic pulmonary arterial hypertension (IPAH), according to a study.

Prognosis role of blood urea nitrogen to serum albumin ratio established in IPAH

03 May 2024

Ranolazine plus AAD helps maintain sinus rhythm after DCCV in persistent AF

03 May 2024 by

Treatment with ranolazine in combination with class III antiarrhythmic drugs (AADs) is associated with improved maintenance of sinus rhythm (SR) 1 year after DC cardioversion (DCCV) relative to class III AAD alone, according to a study presented at EHRA 2024.

Ranolazine plus AAD helps maintain sinus rhythm after DCCV in persistent AF

03 May 2024

Ultra-low temp cryoablation eliminates monomorphic VT: Is it ready for primetime?

03 May 2024 by

Treatment of monomorphic ventricular tachycardia (VT) with a novel ultra-low-temperature cryoablation catheter (vCLAS) eliminates VT in most patients with ischaemic or non-ischaemic cardiomyopathy in the first-in-human Cryocure-VT trial.

Ultra-low temp cryoablation eliminates monomorphic VT: Is it ready for primetime?

03 May 2024

VCS device supports early ambulation without bleeding events after AF ablation

03 May 2024 by

The use of a venous closure system (VCS) post ablation for atrial fibrillation (AF) shortens ambulation time without recurrence of bleeding in the STYLE-AF study presented at EHRA 2024.

VCS device supports early ambulation without bleeding events after AF ablation

03 May 2024

$BP-lowering meds up risk of fractures in older people$

BP-lowering meds up risk of fractures in older people

02 May 2024

Older people who are initiating blood pressure (BP)-lowering medications appear to be at heightened risk of fractures, especially those who have dementia, as shown in a retrospective cohort study.

BP-lowering meds up risk of fractures in older people

02 May 2024

Landiolol reduces heart rate in tachyarrhythmia, LV dysfunction

02 May 2024 by

Use of landiolol, a highly selective and short-acting beta-1 blocker, demonstrates adequate safety and efficacy in terms of heart rate control among patients suffering from atrial tachyarrhythmias (ATs) and left ventricular (LV) dysfunction, suggest the results of a meta-analysis presented at EHRA 2024.

Landiolol reduces heart rate in tachyarrhythmia, LV dysfunction

02 May 2024

Conformable, ‘single-shot’ pulsed field ablation catheter scores high for pulmonary vein isolation

01 May 2024 by

A novel “single-shot,” large-lattice pulsed field ablation (PFA) catheter that conforms to diverse left atrial and pulmonary vein anatomies is safe and efficacious for isolating pulmonary veins in patients with paroxysmal atrial fibrillation (AF), as shown in a first-in-human trial.

Conformable, ‘single-shot’ pulsed field ablation catheter scores high for pulmonary vein isolation

01 May 2024

Anticoagulation of little benefit to patients with device-detected AF, multiple comorbidities

30 Apr 2024 by

Giving oral anticoagulants to patients with device-detected atrial fibrillation (AF) and multiple comorbidities does not necessarily help lower the rate of cardiovascular events, according to a subgroup analysis of the NOAH-AFNET 6 trial.

Anticoagulation of little benefit to patients with device-detected AF, multiple comorbidities

30 Apr 2024

Disrupted delta wave activity during sleep predicts CVD, death

30 Apr 2024

Disruption of the delta wave activity while sleeping may be used to pinpoint individuals who are at heightened risk for cardiovascular disease (CVD) and CVD mortality, according to a study.

Disrupted delta wave activity during sleep predicts CVD, death

30 Apr 2024

News & Updates

Filter by Specialty:

Specialty:

Semaglutide benefits extend to HFpEF patients with T2D

Semaglutide benefits extend to HFpEF patients with T2D

Prognosis role of blood urea nitrogen to serum albumin ratio established in IPAH

Prognosis role of blood urea nitrogen to serum albumin ratio established in IPAH

Ranolazine plus AAD helps maintain sinus rhythm after DCCV in persistent AF

Ranolazine plus AAD helps maintain sinus rhythm after DCCV in persistent AF

Ultra-low temp cryoablation eliminates monomorphic VT: Is it ready for primetime?

Ultra-low temp cryoablation eliminates monomorphic VT: Is it ready for primetime?

VCS device supports early ambulation without bleeding events after AF ablation

VCS device supports early ambulation without bleeding events after AF ablation

BP-lowering meds up risk of fractures in older people

BP-lowering meds up risk of fractures in older people

Landiolol reduces heart rate in tachyarrhythmia, LV dysfunction

Landiolol reduces heart rate in tachyarrhythmia, LV dysfunction

Conformable, ‘single-shot’ pulsed field ablation catheter scores high for pulmonary vein isolation

Conformable, ‘single-shot’ pulsed field ablation catheter scores high for pulmonary vein isolation

Anticoagulation of little benefit to patients with device-detected AF, multiple comorbidities

Anticoagulation of little benefit to patients with device-detected AF, multiple comorbidities

Disrupted delta wave activity during sleep predicts CVD, death

Disrupted delta wave activity during sleep predicts CVD, death